XML 67 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Unaudited Quarterly Operating Results (Tables)
 12 Months Ended
Jun. 30, 2013
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
The following table presents summarized unaudited quarterly results of operations for the years ended June 30, 2012 and 2013. Management believes that all necessary adjustments have been included in the amounts stated below for a fair presentation of the results of operations for the periods presented when read in conjunction with the Company’s consolidated financial statements for the years ended June 30, 2012 and 2013. Results of operations for a particular quarter are not necessarily indicative of results of operations for an annual period and are not predictive of future periods (in millions except per share amounts).
 
September 30,
2011
 
December 31,
2011
 
March 31,
2012
 
June 30,
2012
 
Total revenues
$
1,436.3

 
$
1,475.4

 
$
1,582.5

(2) 
$
1,454.8

 
Net income (loss)
$
(24.0
)
(1) 
$
16.5

 
$
45.0

(2) 
$
18.4

 
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
(21.7
)
(1) 
$
15.7

 
$
44.0

(2) 
$
19.3

 
Basic earnings (loss) per share
$
(0.29
)
 
$
0.21

 
$
0.58

 
$
0.25

 
Diluted earnings (loss) per share
$
(0.29
)
 
$
0.20

 
$
0.55

 
$
0.24

 
 
September 30,
2012
 
December 31,
2012
 
March 31,
2013
 
June 30,
2013
 
Total revenues
$
1,470.7

 
$
1,513.1

 
$
1,498.1

 
$
1,517.5

 
Net income
$
14.9

 
$
12.1

 
$
24.0

 
$
18.1

(3) 
Net income attributable to Vanguard Health Systems, Inc. stockholders
$
13.9

 
$
12.2

 
$
21.3

 
$
14.5

(3) 
Basic earnings per share
$
0.18

 
$
0.15

 
$
0.27

 
$
0.19

 
Diluted earnings per share
$
0.17

 
$
0.14

 
$
0.26

 
$
0.18

 
_____________________

(1) 
This quarterly amount includes a charge of $38.9 million ($25.3 million or $0.32 per diluted share net of taxes) related to the debt extinguishment costs recognized in connection with the majority redemption of the Senior Discount Notes.

(2) 
These amounts include the positive impact of recognizing revenues related to the rural floor provision for approximately $40.6 million and directly related expenses of approximately $7.8 million. The net impact on the quarter ended March 31, 2012 was an increase to net income for approximately $32.8 million ($21.7 million net of taxes or $0.28 per diluted share).

(3) 
These amounts include a gain on the disposition of equipment, certain current assets and third-party customer relationships associated with certain lab services. Related to this sale, the Company received approximately $15.5 million in cash and recognized a gain on sale for approximately $15.2 million ($9.3 million net of taxes or $0.12 per diluted share) during the quarter ended June 30, 2013.